×
About 59,473 results

ALLMedicine™ Thrombosis Center

Research & Reviews  21,293 results

Comparison of coronary artery measurements between echocardiograms and cardiac CT in Ka...
https://doi.org/10.1016/j.jcct.2021.09.002
Journal of Cardiovascular Computed Tomography; Gellis L, Castellanos DA et. al.

Sep 23rd, 2021 - American Heart Association (AHA) guidelines for management of Kawasaki disease (KD) rely on coronary artery (CA) z-scores from echocardiograms. Compared with echocardiography, cardiac CT (CCT) offers better visualization of distal segments and eva...

Epidemiology, Clinical Features, and Outcome in a Cohort of Adolescents With Cerebral V...
https://doi.org/10.1212/WNL.0000000000012828
Neurology Devianne J, Legris N et. al.

Sep 22nd, 2021 - We aimed to analyze the epidemiological, clinical, and paraclinical features of adolescents with cerebral venous thrombosis (CVT) and its therapeutic management and outcome. This multicenter retrospective cohort included patients aged 10-18 years ...

Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccin...
https://doi.org/10.1093/eurheartj/ehab592
European Heart Journal; Hwang J, Park SH et. al.

Sep 22nd, 2021 - The clinical manifestation and outcomes of thrombosis with thrombocytopenia syndrome (TTS) after adenoviral COVID-19 vaccine administration are largely unknown due to the rare nature of the disease. We aimed to analyse the clinical presentation, t...

see more →

Guidelines  60 results

Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Cli...
https://doi.org/10.1016/j.jacc.2021.02.038
Journal of the American College of Cardiology; , Généreux P et. al.

Apr 24th, 2021 - The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evol...

Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice G...
https://doi.org/10.1016/j.ejvs.2020.09.023
European Journal of Vascular and endoVascular Surgery : T... Kakkos SK, Gohel M et. al.

Dec 19th, 2020 - Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.|2020|Kakkos SK,Gohel M,Baekgaard N,Bauersachs R,Bellmunt-Montoya S,|adverse effects,therapeutic use,therapeuti...

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
https://doi.org/10.1016/j.clinre.2020.03.016
Clinics and Research in Hepatology and Gastroenterology; Elkrief L, Houssel-Debry P et. al.

Aug 21st, 2020 - Chronic non cirrhotic extrahepatic portal vein obstruction (EHPVO) refers to the cavernomatous transformation of the portal vein (the so-called "portal cavernoma") which occurs following acute thrombosis of the portal vein in the absence of recana...

ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.035
Journal of the American College of Radiology : JACR; , Farsad K et. al.

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

see more →

Drugs  342 results see all →

News  2,091 results

Genotype-Based Strategy Reduces Thrombotic Events After Watchman Implant
https://www.medscape.com/viewarticle/954762

Jul 15th, 2021 - NEW YORK (Reuters Health) - In patients receiving a Watchman heart device who are genetically predisposed to reduced clopidogrel metabolism, the use of aspirin plus a half-dose of a direct oral anticoagulant (DOAC) significantly reduces device-rel...

Chronic Anticoagulation Fails to Lower AKI Risk in COVID-19 Patients
https://www.medscape.com/viewarticle/954487

Jul 9th, 2021 - Takeaway Chronic anticoagulation does not reduce the risk of acute kidney injury (AKI) and its severity, including the need for renal replacement therapy (RRT) in hospitalised patients with COVID-19. Why this matters Findings suggest that renal mi...

A Woman With DVT After a Flight, Anemia, and Bowel Changes
https://www.medscape.com/viewarticle/855224

Jun 29th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Thrombosis With Thrombocytopenia After mRNA COVID-19 Vaccine
https://www.medscape.com/viewarticle/953901

Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA COVID-19 vaccine has been reported. The case repor...

Abbott Vascular Recalls Coronary Catheters Due to Risks Stemming from Difficulty Removing Balloon Sheath | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/abbott-vascular-recalls-coronary-catheters-due-risks-stemming-difficulty-removing-balloon-sheath

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product(s): Abbott NC Trek RX Coronary Dilatation Catheter, Abbott NC Traveler Coronary Dilatation...

see more →

Patient Education  3 results see all →